No Data
Express News | Jnj-Backed Histosonics Is Pursuing a Sale After Fielding Takeover Bids, Seeking a Valuation of More Than $2.5Bn - FT
8 Health Care Stocks Whale Activity In Today's Session
Johnson & Johnson (JNJ.US) has received FDA approval for a potential blockbuster therapy.
Zhitong Finance APP learned that Johnson & Johnson (JNJ.US) announced that the USA FDA has approved the market launch of its antibody therapy Imaavy (nipocalimab).
On April 30, the top 20 trading volumes in the U.S. stock market: Super Micro Computer's preliminary Earnings Reports significantly missed expectations.
On Wednesday, Tesla, ranked first in U.S. stock trading volume, closed down 3.38% with a transaction volume of 35.226 billion USD. Data shows that as of the week ending April 27, the number of new registered Tesla electric vehicles in the domestic market was 10,300, a 51% increase from the previous week's 6,780, but down 30.5% compared to the same period last year. NVIDIA, ranked second, closed down 0.09% with a transaction volume of 23.471 billion USD. Super Micro Computer, a manufacturer of AI servers, provided a performance forecast that was far below expectations, raising concerns among investors about weak demand for AI servers, which dragged down stocks like NVIDIA. Meta ranked third.
Is Johnson & Johnson (JNJ) the Best Dow Stock for the Next 12 Months?
Express News | J&J Says Wholesale Acquistion Cost or U.S. List Price of Immune Disorder Drug Imaavy Is $12,480 for 1200Mg Vial
loading...
